Synthesis and Characterization of Thermo-Sensitive Nanoparticles for Drug Delivery Applications.
Synthesis and Characterization of Thermo-Sensitive Nanoparticles for Drug Delivery Applications.
复制标题
DOI:
10.1166/jbn.2008.014
复制
发表时间:
2008-12-01
影响因子:
2.9
通讯作者:
Nguyen K
中科院分区:
文献类型:
--
作者:
Rahimi M;Kilaru S;Sleiman GE;Saleh A;Rudkevich D;Nguyen K
The aim of this research project was to develop new temperature sensitive nanoparticles that have a lower critical solution temperature (LCST) that is above body temperature and can be incorporated with various molecules at the surface. The poly(N-isopropylacrylamide-co-acrylamide-co-allylamine) (NIPA-AAm-AH) nanoparticles were synthesized through a free radical polymerization method. NIPA was polymerized with AAm and AH to increase the LCST and to provide amine groups for functionalization, respectively. Using transmission electron microscopy (TEM) and laser scattering technology, the sizes of these nanoparticles were found to be inversely proportional to the surfactant concentrations. In addition, the LCST of the 100-nm NIPA-AAm-AH nanoparticles was approximately 40 °C measured by a spectrophotometer. The chemical composition of the NIPA-AAm-AH nanoparticles determined with Fourier transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR) also confirmed the presence of functional groups of each monomer. The nanoparticles were also successfully conjugated to bovine anti-rabbit IgG-Texas Red as a model for future bioconjugation. Furthermore, nanoparticles did not show significant cytotoxicity activity against human fibroblast cells. Finally, doxorubicin (DOX) was used in order to investigate the drug release profiles of the NIPA-AAm-AH nanoparticles at different temperatures. The results indicated that DOX was released more at 41 °C compared to that of 37 °C and 4 °C, which is evidence for temperature sensitivity of the nanoparticles. Future work will investigate the pharmacological and targeted capabilities of the synthesized nanoparticles conjugated to antibodies for possible application in controlled and targeted drug delivery.
登录
查看更多内容
影响因子:
2.4
作者:
Sarker, Dipak K.
通讯作者:
Sarker, Dipak K.
影响因子:
10.8
作者:
Maeda, H;Wu, J;Hori, K
通讯作者:
Hori, K
影响因子:
3.8
作者:
EHRSSON, H;EKSBORG, S;NILSSON, SO
通讯作者:
NILSSON, SO
影响因子:
6.5
作者:
Khandavilli, Sateesh;Panchagnula, Ramesh
通讯作者:
Panchagnula, Ramesh
DOI:
10.1177/0115426506021004381
发表时间:
2006-08-01
期刊:
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
影响因子:
--
作者:
Driscoll, David F
通讯作者:
Driscoll, David F